Netherlands· NL-8268f899898a

Risedronaatnatrium 35 mg en Calcium 500 mg Aurobindo combinatieverpakking, filmomhulde tabletten

A risedronsäure und calcium, sequenzialpräparate product containing calciumcarbonaat (e 170) + natriumrisedronaat 2,5-water + risedroninezuur, registered in Netherlands by Aurobindo Pharma B.V..

ATC M05BB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about calciumcarbonaat (e 170) + natriumrisedronaat 2,5-water + risedroninezuurAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CALCIUMCARBONAAT (E 170) + NATRIUMRISEDRONAAT 2,5-WATER + RISEDRONINEZUUR
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: M05BB02
ATC class: Risedronsäure und Calcium, Sequenzialpräparate
Defined daily dose: 5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
108300

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M05BB02

Risedronsäure und calcium, sequenzialpräparate, as other registers publish it.

All risedronsäure und calcium, sequenzialpräparate products

NetherlandsActokit, combinatieverpakking, filmomhulde tablettenTheramex Ireland Limited

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4e7a6912-d3b3-4bef-aa99-2fce6cc0e849
GET /v1/drugs/4e7a6912-d3b3-4bef-aa99-2fce6cc0e849?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h108300_smpc.pdf",
  "strength": null,
  "atc_label": "Risedronic Acid And Calcium, Sequential",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg108300",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CALCIUMCARBONAAT (E 170)",
    "NATRIUMRISEDRONAAT 2,5-WATER",
    "RISEDRONINEZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h108300.pdf",
  "authorised_at": "2012/03/27",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "108300",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about risedronsäure und calcium, sequenzialpräparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console